Simponi (SIM-po-nee), a new tumor necrosis factor (TNF) blocker for rheumatoid arthritis

June 2009

Reps will be promoting Simponi (SIM-po-nee), a new tumor necrosis factor (TNF) blocker for rheumatoid arthritis.

It's an alternative to Enbrel, Humira, or Remicade for rheumatoid and other forms of inflammatory arthritis.

There's no proof that any TNF blocker is more effective than another for improving symptoms and slowing progression.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote